Is Trevi Therapeutics, Inc. (TRVI) a Buy, Sell, or Hold?
NASDAQ : TRVI
Trevi Therapeutics, Inc.
$18.145 USD
$0.23 (1.31%)
- Volume
- 1.91M
- Average Volume
- 2.02M
- Market Capitalization
- $2.58B
- P/E Ratio
- -56.32
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $20.15
- Year Low
- $6.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.75
TRVI vs. The Competition
| Properties | TRVI | ARDX | NVAX | ORIC |
|---|---|---|---|---|
| Market Cap | $2.58B | $1.31B | $1.35B | $1.09B |
| Shares Outstanding | $141.98M | $247.03M | $164.44M | $103.52M |
| P/E Ratio | -56.32 | -22.53 | -15.22 | -7.34 |
| EPS | -0.31 | -0.24 | -0.54 | -1.28 |
| Day Low | 17.25 | 5.02 | 8.17 | 10.44 |
| Day high | 18.31 | 5.31 | 8.3686 | 11.2 |
| Year Low | 6.55 | 4.075 | 6.2 | 7.23 |
| Year High | 20.15 | 8.4 | 11.97 | 14.93 |
| Average Price 50 | 15.5739 | 5.9169 | 9.3218 | 9.0707 |
| Average Price 200 | 12.65773 | 6.03998 | 8.5432 | 10.6762 |
| Volume | 1.91M | 2.67M | 1.43M | 393.4K |
| Average Volume | - | - | - | - |